Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line

Journal of Steroid Biochemistry and Molecular Biology

Volumn 64, Issue 1-2, 1998, Pages 43-48

  Lévesque, Eric ^a   Beaulieu, Martin ^a   Guillemette, Chantal ^a   Hum, Dean W ^a   Bélanger, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANDROSTANOLONE; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GLUCURONOSYLTRANSFERASE;

ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GLUCURONIDATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PROSTATE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANDROGENS; CELL DIVISION; DIHYDROTESTOSTERONE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GLUCURONATES; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; STEROIDS; TUMOR CELLS, CULTURED;

EID: 0039453721     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00137-4     Document Type: Article

References (44)

1. Savarese D. M. F., Savarese T. M., Valinski H., Quesenberry P. J. Expression of cytokines, colony-stimulating factors and their receptors in human prostatic carcinoma cell lines. Proc. Am. Assoc. Cancer Res. 36:1995;642.
2. Steiner M. S. Role of peptide growth factors in the prostate: A review. Urology. 42:1993;99-110.
3. Habib F. K., Chislom G. D. The role of growth factors in the human prostate. Scand. J. Urol. Nephrol. Suppl. 138:1991;53-58.
4. Gleave M. E., Hsieh J. T., Wu H. C., von Eschenbach A. C., Chung L. W. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res. 52:1992;1598-1605.
5. Henttu P., Vihko P. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res. 53:1993;1051-1058.
6. Knabbe C., Kellner U., Schmahl M., Voigt K. D. Growth factors in human prostate cancer cells: Implications for an improved treatment of prostate cancer. J. Steroid Biochem. Molec. Biol. 40:1991;185-192.
7. MacDonald A., Habib F. K. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br. J. Cancer. 65:1992;177-182.
8. Wilding G. Response of prostate cancer cells to peptide growth factors: transforming growth factor β Cancer Surv. 11:1991;147-163.
9. Wilding G., Valverius E., Knabbe C., Gelmann E. P. Role of transforming growth factor α in human prostate cell growth. Prostate. 15:1989;1-12.
10. Schuurmans A. L. G., Bolt J., Mulder E. Androgens and transforming growth factor in human prostatic tumor cells. Mol. Cell. Endocrinol. 60:1988;101-104.
11. Hofer D. R., Sherwood E. R., Bromberg W. D., Mendelsohn J., Lee C., Kozlowski J. M. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor α Cancer Res. 51:1991;2780-2785.
12. Chung L. W. K. The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv. 23:1995;33-42.
13. Carruba G., Leake R. E., Rinaldi F., Chalmers D., Comito L., Sorci C., Pavone Macaluso M., Castagnetta L. A. Steroid-growth factor interaction in human prostate cancer. Steroids. 59:1994;412-420.
14. Gleave M. E., Hsieh J. T., von Eschenbach A. C., Chung L. W. Prostate and bone fibroblasts induce human prostate cancer growth in vivo: Implications bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J. Urol. 147:1992;1151-1159.
15. Nakamoto T., Chang C., Li A., Chodak G. W. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res. 52:1992;571-577.
16. Mori H., Maki M., Oishi K., Jaye M., Igarashi K., Yoshida O., Hatanaka M. Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia. Prostate. 16:1990;71-80.
17. Rogelj S., Weinberg R. A., Fanning P., Klagsbrun M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature. 331:1988;173-175.
18. Payson R. A., Canatan H., Chotani M. A., Wang W. P., Harris S. E., Myers R. L., Chiu I. M. Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA. Nucleic Acids Res. 21:1993;489-495.
19. Jouanneau J., Gavrilovic J., Caruelle D., Jaye M., Moeons G., Caruelle J. P., Thiery J. P. Secreted or non secreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. 88:1991;2893-2897.
20. Reed M. J., Coldham N. G., Patel S. R., Ghilchick M. W., James V. H. T. Interleukin-1 and interleukin-6 in breast cyst fluid: Their role in regulating aromatase activity in breast cancer cells. J. Endocrinol. 132:1992;R5-R8.
21. Wahe M., Antonipillai I., Horton R. Effects of transforming growth factor beta and epidermal growth factor on steroid 5α-reductase activity in genital skin fibroblasts. Mol. Cell. Endocrinol. 98:1993;55-59.
22. Horton R., Pasupuletti V., Antonipillai I. Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-I. Endocrinology. 133:1993;447-451.
23. Feinberg B. B., Anderson D. J., Steller M. A., Fulop V., Berkowitz R. S., Hill J. A. Cytokines regulation of trophoblast steroidogenesis. J. Clin. Endocrinol. Metab. 78:1994;586-591.
24. Lebrethon M. C., Jaillard C., Naville D., Begeot M., Saez J. M. Regulation of corticotropin and steroidogenic enzyme mRNAs in human fetal adrenal cells by corticotropin, angiotensin-II and transforming growth factor β1. Mol. Cell. Endocrinol. 106:1994;137-143.
25. Reed M. J., Purohit A., Duncan L. J., Singh A., Roberts C. J., Williams G. J., Potter B. V. L. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumors. J. Steroid Biochem. Molec. Biol. 53:1995;413-420.
26. Burchell B., Coughtrie M. W. UDP-glucuronosyltransferases. Pharmacol. Ther. 43:1989;261-289.
27. Dutton G. J. Developmental aspects of drug conjugation, with special reference to glucuronidation. Annu. Rev. Pharmacol. Toxicol. 18:1978;17-35.
28. Tephly T. R., Burchell B. UDP-glucuronosyltransferases: A family of detoxifying enzymes. Trends Pharmacol. Sci. 11:1990;276-279.
29. Mulder G. J. Glucuronidation and its role in regulation of biological activity of drugs. Annu. Rev. Pharmacol. Toxicol. 32:1992;25-49.
30. Burchell, B., Coughtrie, M. W. H. and Jansen, P. L. M., Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease. Report of the 7th International Workshop on Glucuronidation, September 1993, Pitlochry, Hepatology 20 (1994) 1622-1630.
31. Clarke, D. J. and Burchell, B., The uridine diphosphate glucuronosyltransferase multigene family: function and regulation. in Handb. Exp. Pharm., ed. C. K. Frederic, F. C., 112 (1994) pp. 3-43.
32. Bélanger A., Couture J., Caron S., Roy R. Determination of nonconjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. Ann. N.Y. Acad. Sci. 595:1990;251-259.
33. Bélanger A., Brochu M., Lacoste D., Noel C., Labrie F., Dupont A., Cusan L., Caron S., Couture J. Steroid glucuronides: Human circulatory levels and formation by LNCaP cells. J. Steroid Biochem. Molec. Biol. 40:1991;593-598.
34. Beaulieu M., Lévesque E., Hum D. W., Bélanger A. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J. Biol. Chem. 271:1996;22855-22862.
35. Guillemette, C., Lévesque, E., Beaulieu, M., Turgeon, D., Hum, W. D. and Bélanger, A., Differential regulation of two UDP-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology (1997) 2998-3005.
36. Negri-Cesi P., Motta M. Androgen metabolism in the human prostatic cancer cell line LNCaP. J. Steroid Biochem. Molec. Biol. 51:1994;89-96.
37. Bélanger G., Beaulieu M., Marcotte B., Lévesque E., Guillemette C., Hum D. W., Bélanger A. Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line. Mol. Cell. Endocrinol. 113:1995;165-173.
38. Lévesque, E., Beaulieu, M., Green, M. D., Tephly, T. R., Bélanger, A. and Hum, D. W., Isolation and characterization of UGT2B15(Y85): A UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics (1997) 317-325.
39. Chen F., Ritter J. K., Wang M. G., Mcbride O. W., Lubet R. A., Owens I. S. Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry. 32:1993;10648-10657.
40. Green M., Oturu E. M., Tephly T. R. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab. Disp. 22:1994;799-805.
41. Beaulieu, M., Lévesque, E., Tchernof, A., Beatty, B., Bélanger, A. and Hum, D. W., Chromosomal localization, structure and regulation of the UGT2B17 gene, encoding a steroid metabolizing enzyme. DNA Cell Biol. (1997) 1143-1154.
42. Guillemette C., Bélanger A. Glucuronosyltransferase activity in human cancer cell line LNCaP. Mol. Cell. Endocrinol. 107:1995;131-139.
43. Kramer C. Extension of multiple range tests to group means with unique number of replications. Biometrics. 12:1956;307-310.
44. Zuck B., Goepfert C., Nedlin-Chittka A., Sohrt K., Voigt K. D., Knabbe C. Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP. J. Steroid Biochem. Molec. Biol. 41:1992;659-663.